This page is dedicated to the Esophageal Atresia research study, one of over 60 studies supported by the Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
The Esophageal Atresia research study is led by Dr. Wendy Chung.